| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 0.80 | 89.3% | |
| Total Income | 1.13 | 167.5% | 1597.6% |
| Expenditure | 0.19 | 89.4% | 205.9% |
| PBT | 0.94 | 191.2% | 16186.2% |
| Net Profit | 0.39 | 19.3% | 180.2% |
| OPM | 78.00% | 1.27pp | |
| NPM | 34.28% | 42.62pp | |
| EPS | 0.10 | 25.0% | 28.6% |
Bridge Securities Q4 & FY26 Results Approved; Auditors Appointed
21 Apr 2026 · 21 Apr, 1:43 pm
Summary
BRIDGE SECURITIES LIMITED announced its financial results for the quarter and year ended March 31, 2026. For the full fiscal year 2026, the company reported a Net Profit of ₹155.08 lakhs, marking a 21.70% increase from ₹127.43 lakhs in FY25. Total Income also saw robust growth, rising by 25.54% year-on-year to ₹248.16 lakhs. In the fourth quarter of FY26, Net Profit significantly improved to ₹38.76 lakhs from a loss of ₹48.33 lakhs in the same period last year, alongside a substantial quarter-on-quarter revenue growth of 89.34% from operations. The Board also approved key auditor appointments for the upcoming fiscal years.
Key Highlights
- 1
BRIDGE SECURITIES LIMITED reported a Net Profit of ₹155.08 lakhs for the full fiscal year 2026, marking a 21.70% increase from ₹127.43 lakhs in FY25.
- 2
The company's total income for FY26 grew by 25.54% year-on-year, reaching ₹248.16 lakhs compared to ₹197.69 lakhs in the previous fiscal year.
- 3
For the fourth quarter of FY26, Net Profit significantly improved to ₹38.76 lakhs, a substantial turnaround from a loss of ₹48.33 lakhs reported in Q4 FY25.
- 4
Q4 FY26 total income surged to ₹113.07 lakhs, an impressive growth from ₹6.66 lakhs in Q4 FY25.
- 5
Revenue from operations for Q4 FY26 stood at ₹80.01400 lakhs, demonstrating a strong quarter-on-quarter growth of 89.34% from ₹42.26 lakhs in Q3 FY26.
- 6
The Board of Directors approved the appointment of M/s. Jitendra Parmar & Associates as Secretarial Auditor for FY2025-26 and M/s. Bhaumik Shah & Co. as Internal Auditor for FY2026-27.
Informational and educational content only. Not investment advice.